ASSOCIATION BETWEEN FORMULARY STRATEGIES AND HOSPITAL DRUG EXPENDITURES

被引:20
|
作者
HAZLET, TK
HU, TW
机构
[1] UNIV CALIF SAN FRANCISCO,SCH PHARM,SAN FRANCISCO,CA 94143
[2] UNIV CALIF BERKELEY,SCH PUBL HLTH,DEPT HLTH POLICY & ADM,BERKELEY,CA 94720
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1992年 / 49卷 / 09期
关键词
ADMINISTRATION; COSTS; ECONOMICS; FORMULARIES; HOSPITALS; PHARMACY; INSTITUTIONAL; HOSPITAL; SUBSTITUTION;
D O I
10.1093/ajhp/49.9.2207
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
National survey data were analyzed to determine whether an association existed between formulary strategies and hospital drug expenditures. Data on community hospitals were obtained from (1) ASHP's 1987 national survey of pharmaceutical services, (2) the American Hospital Association, and (3) the Health Care Financing Administration. Along with size, case mix, and salary information, data were collected on whether the hospitals used a well-controlled formulary, whether they used therapeutic interchange, and how much money they spent on drugs. A logarithmic cost-function model was used to obtain a straight-line equation that expressed the relationships between drug cost per patient day and the other variables assessed. Summary statistics were calculated with data from 514 hospitals. The adjusted coefficient of multiple determination indicated that the model was able to explain 24.6% of the observed variation in drug cost per patient day. A significant association was found between decreased costs and a well-controlled formulary, therapeutic interchange, or both. Hospitals that used either strategy spent 10.7% less for drugs than those that used neither. Hospitals that used both strategies spent 13.4% less than those that used neither. Analysis of national survey data suggests that use of a well-controlled formulary, therapeutic interchange, or both are associated with lower pharmacy drug expenditures.
引用
收藏
页码:2207 / 2210
页数:4
相关论文
共 50 条
  • [41] MEDICAID FORMULARY RESTRICTIONS AND EXPENDITURES FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Seabury, S.
    Lakdawalla, D. N.
    Walter, D.
    Hayes, J.
    Gustafson, T.
    Shrestha, A.
    Goldman, D. P.
    VALUE IN HEALTH, 2014, 17 (03) : A222 - A222
  • [42] The association between body mass and health care expenditures
    Heithoff, KA
    Cuffel, BJ
    Kennedy, S
    Peters, J
    CLINICAL THERAPEUTICS, 1997, 19 (04) : 811 - 820
  • [43] Prescription pattern analysis and compliance to drug formulary in a tertiary care hospital - an observational study
    Shilpashri, D.
    Anjana, P.
    Manoj, Y.
    Zainab, G.
    Cuckoo, A.
    Shivamurthy, M. C.
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S148 - S148
  • [44] IAP Drug Formulary 2004
    Unni, JC
    INDIAN PEDIATRICS, 2006, 43 (03) : 274 - 275
  • [45] Rationalization of pharmaceuticals utilization by means of drug formulary: The pilot project in belarussian multiprofile hospital
    Mily, Maxim N.
    Sachek, Marina M.
    Lugovoy, Vladimir Y.
    Golubev, Sergey A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S212 - S212
  • [46] Hospital Reimbursement Price Cap for Cancer DrugsThe French Experience in Controlling Hospital Drug Expenditures
    Albane Degrassat-Théas
    M. Bensadon
    C. Rieu
    M. Angalakuditi
    C. Le Pen
    P. Paubel
    PharmacoEconomics, 2012, 30 (7) : 565 - 573
  • [47] Hospital Reimbursement Price Cap for Cancer Drugs The French Experience in Controlling Hospital Drug Expenditures
    Degrassat-Theas, A.
    Bensadon, M.
    Rieu, C.
    Angalakuditi, M.
    Le Pen, C.
    Paubel, P.
    PHARMACOECONOMICS, 2012, 30 (07) : 565 - 573
  • [48] Formulary Drug Review: Odevixibat
    Levien, Terri L.
    Baker, Danial E.
    HOSPITAL PHARMACY, 2023, 58 (02) : 125 - 133
  • [49] Formulary Drug Review: Belumosudil
    Levien, Terri L.
    Baker, Danial E.
    HOSPITAL PHARMACY, 2022, 57 (04) : 435 - 441
  • [50] MEDICAID DRUG FORMULARY RESTRICTIONS
    DRANOVE, D
    JOURNAL OF LAW & ECONOMICS, 1989, 32 (01): : 143 - 162